1-3 of 3
Wenhua Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Strikingly Reduced Toxicities of Fotemustine-Based Chemotherapeutics Than High-Dose Methotrexate-Containing Regimens with Comparable Efficacy

Xudong Zhang, Mengke Fan, Wenhua Wang, Jingjing Wu, Shanshan Ma, Meng Dong, Linan Zhu, Xiaolong Wu, Xiaoyan Feng, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Yu Chang, Hui Yu, Feifei Nan, Zhiyuan Zhou, Mengjie Ding, Jieming Zhang, Lei Zhang, Mingzhi Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6458.
https://doi.org/10.1182/blood-2024-202107
Published: 2024
Journal Articles

A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)

Xudong Zhang, Wenhua Wang, Shanshan Ma, Mengke Fan, Linan Zhu, Lei Zhang, Xin Li, Ling Li, Zhenchang Sun, Xinhua Wang, Xiaorui Fu, Zhaoming Li, Jiaqin Yan, Mingzhi Zhang
Journal: Blood
Blood (2022) 140 (Supplement 1): 12075–12076.
https://doi.org/10.1182/blood-2022-159383
Published: 2022
Journal Articles

Fotemustine-Containing Regimens Versus Regimens Based on High-Dose Methotrexate in Newly Diagnosed PCNSL

Jingjing Wu, Mingzhi Zhang, Wenhua Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4559.
https://doi.org/10.1182/blood-2021-154337
Published: 2021